Author:
Cheng Jie,Wang Yanling,Yu Hongbo,Wang Dongmiao,Ye Jinhai,Jiang Hongbin,Wu Yunong,Shen Guofang
Abstract
Abstract
Background
Craniomaxillofacial fibrous dysplasia (FD) is a benign bone lesion characterized by facial disfigurement and functional impairment. The aim of this study was to characterize the epidemiological and clinical features of craniomaxillofacial FD by presenting data from a representative Chinese population during a 15-year period (1994–2009).
Method
The craniomaxillofacial disease registries of two Chinese tertiary referral hospitals (Shanghai Ninth People’s Hospital and Stomatological hospital of Jiangsu Province) were searched and reviewed to collect relevant information for patients with craniomaxillofacial FD between Jan.1994 and Dec.2009. All included cases were further analyzed with regard to associated epidemiological and clinicopathological variables.
Results
A total number of 266 cases with definitive diagnosis were identified with 219 primary cases and 47 recurrent cases. There were 111 males and 155 females with a male to female ratio of 0.716:1. They were clinically categorized into three groups: monostotic (71.1%), polysotic (27.4%) and Albright syndrome (1.5%). Maxilla alone or with adjacent bones was the most common affected site. The serum alkaline phosphatase (ALP) in patients was much higher than that in healthy control, whereas comparable between primary patients and recurrent ones. Three patients (3/266, 1.1%) with polysotic lesions underwent spontaneous malignant transformation into osteosarcoma. The majority of patients underwent conservative surgery, while the others received radical resection with or without reconstruction.
Conclusions
Craniomaxillofacial FD is a rare bony disorder with defined epidemiological and clinicopathological features in Chinese population. Further investigations are warranted to establish the optimized timing, treatment strategy and prognostic prediction for this clinical entity.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Genetics (clinical),General Medicine
Reference22 articles.
1. DiCaprio MR, Enneking WF: Fibrous dysplasia. Pathophysiology, evaluation, and treatment. J Bone Joint Surg Am. 2005, 87: 1848-1864. 10.2106/JBJS.D.02942.
2. Posnick JC: Fibrous dysplasia of the craniomaxillofacial region: current clinical perspectives. Br J Oral Maxillofac Surg. 1998, 36: 264-273. 10.1016/S0266-4356(98)90710-0.
3. Kruse A, Pieles U, Riener MO, Zunker C, Bredell MG, Gratz KW: Craniomaxillofacial fibrous dysplasia: a 10-year database 1996–2006. Br J Oral Maxillofac Surg. 2009, 47: 302-305. 10.1016/j.bjoms.2009.01.008.
4. Marie PJ, de Pollak C, Chanson P, Lomri A: Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia. Am J Pathol. 1997, 150: 1059-1069.
5. Rahman AM, Madge SN, Billing K, Anderson PJ, Leibovitch I, Selva D, David D: Craniofacial fibrous dysplasia: clinical characteristics and long-term outcomes. Eye (Lond). 2009, 23: 2175-2181. 10.1038/eye.2009.6.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献